Routine Chest X-rays After COVID-19
Routine chest X-rays are not recommended after COVID-19 infection unless patients have persistent respiratory symptoms, functional impairment, or were hospitalized with moderate-to-severe disease. 1
Evidence-Based Approach to Post-COVID Imaging
When Chest Imaging IS Indicated:
Patients with persistent symptoms after COVID-19:
Patients with history of severe COVID-19 infection:
Evidence of worsening respiratory status in recovered patients 1
When Chest Imaging IS NOT Indicated:
Asymptomatic individuals (regardless of COVID-19 history) 1
Patients with mild COVID-19 features (no hypoxemia, no or mild dyspnea) unless they have risk factors for disease progression 1
Routine follow-up in patients who have recovered without persistent symptoms 1
Stable intubated patients with COVID-19 (daily chest radiographs are NOT indicated) 1
Imaging Selection When Indicated
Initial imaging: PA and lateral chest radiography (preferred over portable AP radiography when feasible) 1
For persistent/concerning symptoms: Consider CT chest without contrast for patients with:
- Functional impairment
- Hypoxemia after recovery
- History of moderate-to-severe COVID-19 infection 1
Common Pitfalls to Avoid
Unnecessary radiation exposure: Routine use of chest X-rays for asymptomatic recovered patients leads to unnecessary radiation exposure with low diagnostic yield 2
Resource constraints: In resource-limited settings, CXR may be preferred over CT unless features of respiratory worsening warrant CT use 1
Misinterpretation: Recognize that some radiographic abnormalities may persist after clinical recovery, particularly in patients who had severe disease, without necessarily requiring intervention 1
Lack of standardized reporting: When imaging is performed, standardized reporting language should be used to ensure consistency and facilitate comparison between examinations 3
By following these evidence-based guidelines, clinicians can appropriately select patients who would benefit from post-COVID chest imaging while avoiding unnecessary testing in those who are unlikely to have clinically significant findings.